Stran 1 iz 86 rezultatov
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates generally to novel methods for enhancing the biological activity of chemotherapeutic agents. More specifically, the invention pertains to unique methods for increasing the toxicity of cytostatic hydrophobic chemotherapeutic
FIELD OF THE INVENTION
The present invention relates to a method for treating pancreatic cancer in humans.
BACKGROUND OF THE INVENTION
20(S)-camptothecin (CPT), a plant alkaloid, was found to have anticancer activity in 1966 (Wall, M., Wani, M. C., Cooke, C. E., Palmer, K. H., McPhail, A. T. and
FIELD OF THE INVENTION
The present invention relates to an improved method for the production of antibodies to tumor-associated gangliosides using ganglioside lactones. The resulting antibodies are useful in the detection and treatment of tumors containing gangliosides. The present invention also
FIELD OF THE INVENTION
The present invention relates to an improved method for the production of antibodies to tumor-associated gangliosides using ganglioside lactones. The resulting antibodies are useful in the detection and treatment of tumors containing gangliosides. The present invention also
FIELD OF THE INVENTION
The present invention relates to an improved method for the production of antibodies to tumor-associated gangliosides using ganglioside lactones. The resulting antibodies are useful in the detection and treatment of tumors containing gangliosides. The present invention also
FIELD OF THE INVENTION
The present invention relates to a method for treating cancer in mammals, more particularly, to a method for treating malignant tumors such as lung, breast, stomach, pancreatic, prostate, bladder, osteosarcoma and ovary carcinomas and malignant melanomas.
BACKGROUND OF THE
FIELD OF THE INVENTION
The present invention relates to a method for treating cancer in mammals, more particularly, to a method for treating malignant tumors such as lung, breast, stomach, pancreatic, prostate, bladder, osteosarcoma and ovary carcinomas and malignant melanomas.
BACKGROUND OF THE
FIELD OF THE INVENTION
The present invention relates to a method for treating cancer in mammals, more particularly, to a method for treating malignant tumors such as lung, breast, stomach, pancreatic, prostate, bladder, osteosarcoma and ovary carcinomas and malignant melanomas.
BACKGROUND OF THE
FIELD OF THE INVENTION
The present invention relates to a method for treating cancer in mammals, more particularly, to a method for treating malignant tumors such as lung, breast, stomach, pancreatic, prostate, bladder, osteosarcoma and ovary carcinomas and malignant melanomas.
BACKGROUND OF THE
FIELD OF THE INVENTION
The present invention relates to a method for treating cancer in mammals, more particularly, to a method for treating malignant tumors such as lung, breast, stomach, pancreatic, prostate, bladder, osteosarcoma and ovary carcinomas and malignant melanomas.
BACKGROUND OF THE
FIELD OF THE INVENTION
The present invention relates to a method for treating cancer in mammals, more particularly, to a method for treating malignant tumors such as lung, breast, stomach, pancreatic, prostate, bladder, osteosarcoma and ovary carcinomas and malignant melanomas.
BACKGROUND OF THE
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to compounds and methods for obtaining such compounds in the fields of chemistry and medicine. More specifically, the present invention relates to compounds and procedures for making compounds useful in the treatment
CROSS REFERENCE TO RELATED APPLICATIONS
The present application is a National Stage Application claiming the priority of PCT Application No. PCT/CN2014/071751 filed Jan. 29, 2014, which in turn claims priority to Chinese Application Serial No. 2013/10034985.5 filed Jan. 30, 2013. Applicants claim
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is the U.S. national stage application of International Patent Application No. PCT/EP2011/062243, filed Jul. 18, 2011, which claims priority to Swedish Application No. 1050815-8, filed Jul. 19, 2010, the disclosures of each of which are
CROSS-REFERENCE TO RELATED APPLICATION
This application is related to our copending PCT application entitled: "USE OF MACROCYCLIC LACTONE DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISORDERS", filed on the same date as the present application.
FIELD OF THE INVENTION
The present invention relates